Edition:
United States

Core Laboratories NV (CLB)

CLB on New York Consolidated

110.94USD
29 Sep 2016
Change (% chg)

$2.68 (+2.48%)
Prev Close
$108.26
Open
$109.24
Day's High
$111.90
Day's Low
$108.64
Volume
818,839
Avg. Vol
463,453
52-wk High
$135.49
52-wk Low
$84.50

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 0.39 December 29 Sep 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 6 6 6 6
(3) HOLD 7 6 6 6
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.25 2.20 2.20 2.20

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 10 147.61 151.00 141.70 210.05
Quarter Ending Dec-16 10 149.64 155.00 143.80 215.50
Year Ending Dec-16 16 600.95 607.90 587.20 854.33
Year Ending Dec-17 16 670.06 724.10 633.00 935.27
Earnings (per share)
Quarter Ending Sep-16 17 0.39 0.41 0.38 0.91
Quarter Ending Dec-16 17 0.42 0.47 0.40 0.96
Year Ending Dec-16 17 1.55 1.65 1.50 3.71
Year Ending Dec-17 19 2.29 2.71 1.66 4.52
LT Growth Rate (%) 2 10.41 20.00 0.81 18.00

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-16 146.40 148.07 1.67 1.14
Quarter Ending Mar-16 158.42 153.65 4.78 3.01
Quarter Ending Dec-15 178.84 182.72 3.88 2.17
Quarter Ending Sep-15 201.06 197.26 3.79 1.89
Quarter Ending Jun-15 194.39 203.89 9.50 4.89
Earnings (per share)
Quarter Ending Jun-16 0.35 0.35 0.00 0.88
Quarter Ending Mar-16 0.37 0.37 0.00 0.16
Quarter Ending Dec-15 0.65 0.65 0.00 0.00
Quarter Ending Sep-15 0.83 0.83 0.00 0.10
Quarter Ending Jun-15 0.77 0.82 0.05 6.49

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 147.61 149.88 149.83 149.83 210.05
Quarter Ending Dec-16 149.64 152.47 152.48 152.48 215.50
Year Ending Dec-16 600.95 604.90 604.79 604.41 854.33
Year Ending Dec-17 670.06 678.06 685.52 691.30 935.27
Earnings (per share)
Quarter Ending Sep-16 0.39 0.40 0.40 0.40 0.91
Quarter Ending Dec-16 0.42 0.44 0.44 0.44 0.96
Year Ending Dec-16 1.55 1.58 1.58 1.57 3.71
Year Ending Dec-17 2.29 2.32 2.39 2.42 4.52

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-16 0 4 0 4
Quarter Ending Dec-16 0 4 0 4
Year Ending Dec-16 0 5 0 5
Year Ending Dec-17 0 5 0 6
Earnings
Quarter Ending Sep-16 0 7 0 7
Quarter Ending Dec-16 1 6 1 5
Year Ending Dec-16 0 6 0 6
Year Ending Dec-17 0 7 0 7

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Stock Traders Daily
$20.00
Provider : New Constructs, LLC
$25.00
Provider : MacroRisk Analytics/EconomicInvestor
$25.00
Provider : ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.